• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经退行性疾病和重度抑郁症中抑郁症状快速自评量表的拉施分析

Rasch analyses of the Quick Inventory of Depressive Symptomatology Self-Report in neurodegenerative and major depressive disorders.

作者信息

Vaccarino Anthony L, Black Sandra E, Gilbert Evans Susan, Frey Benicio N, Javadi Mojib, Kennedy Sidney H, Lam Benjamin, Lam Raymond W, Lasalandra Bianca, Martens Emily, Masellis Mario, Milev Roumen, Mitchell Sara, Munoz Douglas P, Sparks Alana, Swartz Richard H, Tan Brian, Uher Rudolf, Evans Kenneth R

机构信息

Indoc Research, Toronto, ON, Canada.

Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada.

出版信息

Front Psychiatry. 2023 Jun 2;14:1154519. doi: 10.3389/fpsyt.2023.1154519. eCollection 2023.

DOI:10.3389/fpsyt.2023.1154519
PMID:37333922
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10273843/
Abstract

BACKGROUND

Symptoms of depression are present in neurodegenerative disorders (ND). It is important that depression-related symptoms be adequately screened and monitored in persons living with ND. The Quick Inventory of Depressive Symptomatology Self-Report (QIDS-SR) is a widely-used self-report measure to assess and monitor depressive severity across different patient populations. However, the measurement properties of the QIDS-SR have not been assessed in ND.

AIM

To use Rasch Measurement Theory to assess the measurement properties of the Quick Inventory of Depressive Symptomatology Self-Report (QIDS-SR) in ND and in comparison to major depressive disorder (MDD).

METHODS

De-identified data from the Ontario Neurodegenerative Disease Research Initiative (NCT04104373) and Canadian Biomarker Integration Network in Depression (NCT01655706) were used in the analyses. Five hundred and twenty participants with ND (Alzheimer's disease or mild cognitive impairment, amyotrophic lateral sclerosis, cerebrovascular disease, frontotemporal dementia and Parkinson's disease) and 117 participants with major depressive disorder (MDD) were administered the QIDS-SR. Rasch Measurement Theory was used to assess measurement properties of the QIDS-SR, including unidimensionality and item-level fit, category ordering, item targeting, person separation index and reliability and differential item functioning.

RESULTS

The QIDS-SR fit well to the Rasch model in ND and MDD, including unidimensionality, satisfactory category ordering and goodness-of-fit. Item-person measures (Wright maps) showed gaps in item difficulties, suggesting poor precision for persons falling between those severity levels. Differences between mean person and item measures in the ND cohort logits suggest that QIDS-SR items target more severe depression than experienced by the ND cohort. Some items showed differential item functioning between cohorts.

CONCLUSION

The present study supports the use of the QIDS-SR in MDD and suggest that the QIDS-SR can be also used to screen for depressive symptoms in persons with ND. However, gaps in item targeting were noted that suggests that the QIDS-SR cannot differentiate participants falling within certain severity levels. Future studies would benefit from examination in a more severely depressed ND cohort, including those with diagnosed clinical depression.

摘要

背景

神经退行性疾病(ND)患者存在抑郁症状。对ND患者的抑郁相关症状进行充分筛查和监测非常重要。抑郁症状快速自评量表(QIDS-SR)是一种广泛使用的自评工具,用于评估和监测不同患者群体的抑郁严重程度。然而,QIDS-SR在ND中的测量特性尚未得到评估。

目的

运用拉施测量理论评估抑郁症状快速自评量表(QIDS-SR)在ND中的测量特性,并与重度抑郁症(MDD)进行比较。

方法

分析来自安大略神经退行性疾病研究倡议(NCT04104373)和加拿大抑郁症生物标志物整合网络(NCT01655706)的匿名数据。对520名ND患者(阿尔茨海默病或轻度认知障碍、肌萎缩侧索硬化症、脑血管疾病、额颞叶痴呆和帕金森病)和117名重度抑郁症(MDD)患者进行QIDS-SR测评。运用拉施测量理论评估QIDS-SR的测量特性,包括单维度性和项目水平拟合、类别排序、项目靶向、人员分离指数以及信度和项目功能差异。

结果

QIDS-SR在ND和MDD中与拉施模型拟合良好,包括单维度性、令人满意的类别排序和拟合优度。项目-人员测量(赖特图)显示项目难度存在差距,表明处于这些严重程度水平之间的人员精度较差。ND队列对数几率中平均人员测量和项目测量之间的差异表明,QIDS-SR项目针对的是比ND队列所经历的更严重的抑郁症。一些项目在不同队列之间显示出项目功能差异。

结论

本研究支持在MDD中使用QIDS-SR,并表明QIDS-SR也可用于筛查ND患者的抑郁症状。然而,注意到项目靶向存在差距,这表明QIDS-SR无法区分处于特定严重程度水平的参与者。未来的研究将受益于在更严重抑郁的ND队列中进行检查,包括那些被诊断为临床抑郁症的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1075/10273843/8e908ea88ac5/fpsyt-14-1154519-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1075/10273843/4c1208687978/fpsyt-14-1154519-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1075/10273843/8e908ea88ac5/fpsyt-14-1154519-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1075/10273843/4c1208687978/fpsyt-14-1154519-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1075/10273843/8e908ea88ac5/fpsyt-14-1154519-g002.jpg

相似文献

1
Rasch analyses of the Quick Inventory of Depressive Symptomatology Self-Report in neurodegenerative and major depressive disorders.神经退行性疾病和重度抑郁症中抑郁症状快速自评量表的拉施分析
Front Psychiatry. 2023 Jun 2;14:1154519. doi: 10.3389/fpsyt.2023.1154519. eCollection 2023.
2
THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial.抑郁量表发展量表:在CAN - BIND试验中使用经典和现代测量理论对心理测量特性进行评估
Innov Clin Neurosci. 2020 Jul 1;17(7-9):30-40.
3
Guidance on the conversion of the Chinese versions of the Quick Inventory of Depressive Symptomatology-Self-Report (C-QIDS-SR) and the Montgomery-Asberg Scale (C-MADRS) in Chinese patients with major depression.关于重性抑郁障碍患者中文版本的快速抑郁症状自评量表(C-QIDS-SR)和蒙哥马利-艾斯伯格抑郁评定量表(C-MADRS)转换的指导。
J Affect Disord. 2014 Jan;152-154:530-3. doi: 10.1016/j.jad.2013.09.023. Epub 2013 Oct 4.
4
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation.公共部门心境障碍患者的抑郁症状量表临床医生评定版(IDS-C)与自评版(IDS-SR)以及快速抑郁症状量表临床医生评定版(QIDS-C)与自评版(QIDS-SR):一项心理测量学评估
Psychol Med. 2004 Jan;34(1):73-82. doi: 10.1017/s0033291703001107.
5
Reliability and Validity of the Quick Inventory of Depressive Symptomatology-Self-Report Scale in Older Adults With Depressive Symptoms.老年抑郁症状患者中抑郁症状快速自评量表的信度和效度
Front Psychiatry. 2021 Oct 20;12:686711. doi: 10.3389/fpsyt.2021.686711. eCollection 2021.
6
Psychometric properties of the Chinese versions of the Quick Inventory of Depressive Symptomatology - Clinician Rating (C-QIDS-C) and Self-Report (C-QIDS-SR).中文版快速抑郁症状自评量表临床医师评定版(C-QIDS-C)和自评版(C-QIDS-SR)的心理测量学特性。
J Affect Disord. 2013 May;147(1-3):421-4. doi: 10.1016/j.jad.2012.08.035. Epub 2012 Sep 18.
7
Clinical vs. self-report versions of the quick inventory of depressive symptomatology in a public sector sample.公共部门样本中抑郁症状快速清单的临床版与自我报告版对比
J Psychiatr Res. 2007 Apr-Jun;41(3-4):239-46. doi: 10.1016/j.jpsychires.2006.04.001. Epub 2006 May 22.
8
The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.16项抑郁症状快速检查表(QIDS)、临床医生评定版(QIDS-C)和自我报告版(QIDS-SR):对慢性重度抑郁症患者的心理测量学评估
Biol Psychiatry. 2003 Sep 1;54(5):573-83. doi: 10.1016/s0006-3223(02)01866-8.
9
Could the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR) be used in depressed schizophrenia patients?抑郁症状自评快速清单-自我报告(QIDS-SR)能否用于抑郁性精神分裂症患者?
J Affect Disord. 2015 Feb 1;172:191-4. doi: 10.1016/j.jad.2014.09.051. Epub 2014 Oct 13.
10
Psychometric Properties of the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR) in Depressed Adolescents.抑郁青少年抑郁症状快速自评量表(QIDS-SR)的心理测量特性
Front Psychiatry. 2020 Dec 9;11:598609. doi: 10.3389/fpsyt.2020.598609. eCollection 2020.

引用本文的文献

1
Development and initial validation of DESCAQ: A Rasch-based computer-adaptive questionnaire for assessing digital eye strain.DESCAQ的开发与初步验证:一种基于拉施模型的用于评估数字眼疲劳的计算机自适应问卷。
Ophthalmic Physiol Opt. 2025 Sep;45(6):1326-1341. doi: 10.1111/opo.13540. Epub 2025 Jun 14.
2
Assessment of anxiety in children with neurodevelopment disorders: Rasch analysis of the Spence Children's Anxiety Scale.神经发育障碍儿童焦虑症的评估:斯彭斯儿童焦虑量表的拉施分析
Front Psychiatry. 2024 Apr 29;15:1240357. doi: 10.3389/fpsyt.2024.1240357. eCollection 2024.

本文引用的文献

1
Using Rasch measurement for instrument rating scale refinement.运用 Rasch 测量法完善仪器评定量表。
Curr Pharm Teach Learn. 2023 Jan;15(1):110-118. doi: 10.1016/j.cptl.2023.02.015. Epub 2023 Mar 9.
2
Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohort.安大略省神经退行性疾病研究倡议队列的特征。
Alzheimers Dement. 2023 Jan;19(1):226-243. doi: 10.1002/alz.12632. Epub 2022 Mar 30.
3
Rasch Reporting Guideline for Rehabilitation Research (RULER): the RULER Statement.Rasch 康复研究报告准则(RULER):RULER 声明。
Arch Phys Med Rehabil. 2022 Jul;103(7):1477-1486. doi: 10.1016/j.apmr.2022.03.013. Epub 2022 Apr 12.
4
Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain Disorders.促进参与者层面数据共享与再利用的通用数据元素:跨脑疾病的精神共病评估
Front Psychiatry. 2022 Feb 7;13:816465. doi: 10.3389/fpsyt.2022.816465. eCollection 2022.
5
Reliability and Validity of the Quick Inventory of Depressive Symptomatology-Self-Report Scale in Older Adults With Depressive Symptoms.老年抑郁症状患者中抑郁症状快速自评量表的信度和效度
Front Psychiatry. 2021 Oct 20;12:686711. doi: 10.3389/fpsyt.2021.686711. eCollection 2021.
6
Construct Validity and Differential Item Functioning of the PHQ-9 Among Health Care Workers: Rasch Analysis Approach.医疗工作者中患者健康问卷-9(PHQ-9)的结构效度与项目功能差异:Rasch分析方法
Neuropsychiatr Dis Treat. 2021 Apr 8;17:1035-1045. doi: 10.2147/NDT.S271987. eCollection 2021.
7
Somatic symptoms have negligible impact on Patient Health Questionnaire-9 depression scale scores in neurological patients.躯体症状对神经科患者的患者健康问卷-9 抑郁量表评分影响可忽略不计。
Eur J Neurol. 2021 Jun;28(6):1812-1819. doi: 10.1111/ene.14822. Epub 2021 Mar 26.
8
THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial.抑郁量表发展量表:在CAN - BIND试验中使用经典和现代测量理论对心理测量特性进行评估
Innov Clin Neurosci. 2020 Jul 1;17(7-9):30-40.
9
Validity of the Patient Health Questionnaire-9 in neurologic populations.患者健康问卷-9在神经疾病人群中的效度
Neurol Clin Pract. 2020 Jun;10(3):190-198. doi: 10.1212/CPJ.0000000000000748. Epub 2020 Apr 13.
10
Comparison of the Usefulness of the PHQ-8 and PHQ-9 for Screening for Major Depressive Disorder: Analysis of Psychiatric Outpatient Data.PHQ-8与PHQ-9在筛查重度抑郁症中的效用比较:精神科门诊数据的分析
Psychiatry Investig. 2019 Apr;16(4):300-305. doi: 10.30773/pi.2019.02.01. Epub 2019 Apr 24.